Validation and application of a method for the simultaneous absolute quantification of 16 neutral and acidic human milk oligosaccharides by graphitized carbon liquid chromatography - electrospray ionization - mass spectrometry

Abstract

Human milk oligosaccharides (HMOs) are free glycans naturally present in human milk that act as prebiotics, prevent pathogen binding, modulate the immune system and support brain development in infants. The HMOs composition and concentrations vary significantly among different women mainly because of the direct influence of the Secretor and Lewis phenotypes on HMOs biosynthesis. Analytical methods that can identify the differences in the HMOs composition and concentrations are a fundamental tool in HMOs research. This paper describes a simple HMOs extraction and analysis for the simultaneous and absolute quantification of neutral and acidic HMOs by graphitized carbon liquid chromatography-electrospray ionization-mass spectrometry. This method was validated and applied to analyze HMOs in the human milk obtained from 10 women. This method allows accurate and reliable quantification of HMOs and can be used to determine differences in HMOs concentrations throughout lactation and among women with different Secretor and Lewis phenotypes.

Keywords: 2′-Fucosyllactose (PubChem CID: 170484); 3′-Fucosyllactose (PubChem CID: 161460); 3′-Sialyllactose (PubChem CID: 123914); 6′-Sialyllactose (PubChem CID: 643987); Human milk oligosaccharides; LC-ESI-MS; LS-tetrasaccharide b (PubChem CID: 53477864); Lacto-N-difucohexaose I (PubChem CID: 3082109); Lacto-N-difucohexaose II (PubChem CID: 53262301); Lacto-N-fucopentaose I (PubChem CID: 50909802); Lacto-N-hexaose (PubChem CID: 194173); Lacto-N-tetraose (PubChem CID: 440993); Lewis phenotype; Porous graphitic carbon; Sample preparation; Secretor phenotype.